T-cell--depleted allogeneic bone marrow transplantation followed by donor lymphocyte infusion in patients with multiple myeloma: induction of graft-versus-myeloma effect.
暂无分享,去创建一个
J. Gribben | J. Ritz | R. Soiffer | K. Anderson | R. Schlossman | P. Mauch | E. Weller | K. Marcus | C. Canning | E. Alyea | K. Marcus | J. Gribben | R. Soiffer | D. Doss | D. Fisher | A. Freeman | B. Parikh | I. Webb | K. Anderson | David C. Fisher | Iain L. Webb
[1] D. Neuberg,et al. Changes in T cell receptor repertoire associated with graft-versus-tumor effect and graft-versus-host disease in patients with relapsed multiple myeloma after donor lymphocyte infusion , 2000, Bone Marrow Transplantation.
[2] J. Ritz,et al. Comparative outcomes of T-cell-depleted and non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: impact of donor lymphocyte infusion. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] S. Singhal,et al. Graft-versus-myeloma , 1998, Bone Marrow Transplantation.
[4] D. Neuberg,et al. Toxicity and efficacy of defined doses of CD4(+) donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant. , 1998, Blood.
[5] N. Young,et al. T cell-depleted bone marrow transplantation and delayed T cell add-back to control acute GVHD and conserve a graft-versus-leukemia effect , 1998, Bone Marrow Transplantation.
[6] J. Cornelissen,et al. Donor leukocyte infusions are effective in relapsed multiple myeloma after allogeneic bone marrow transplantation. , 1997, Blood.
[7] Robert H. Collins,et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] R. Storb,et al. Allogeneic marrow transplantation for multiple myeloma: an analysis of risk factors on outcome. , 1996, Blood.
[9] B. Barlogie,et al. Graft-versus-myeloma effect: proof of principle. , 1996, Blood.
[10] H. Kantarjian,et al. CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation. , 1995, Blood.
[11] A Ferrant,et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. , 1995, Blood.
[12] S. Mackinnon,et al. Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease. , 1995, Blood.
[13] A. Hagenbeek,et al. Prognostic factors in allogeneic bone marrow transplantation for multiple myeloma. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] P. Duffey,et al. Transfer of myeloma idiotype-specific immunity from an actively immunised marrow donor , 1995, The Lancet.
[15] J. Goldman,et al. Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: the case for giving donor leukocyte transfusions before the onset of hematologic relapse. , 1994, Blood.
[16] A. Rimm,et al. Graft-versus-leukemia reactions after bone marrow transplantation. , 1990, Blood.
[17] R. Hoffmann,et al. Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion. , 1988 .
[18] L Davies,et al. Bone marrow transplant. , 1985, Nursing times.
[19] E. Baráth,et al. Fundamentals of Biostatistics. , 1992 .
[20] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .